日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Convergent Genetic Adaptation in Human Tumors Developed Under Systemic Hypoxia and in Populations Living at High Altitudes

在全身性缺氧和高海拔地区人群中,人类肿瘤的趋同遗传适应

Carlota Arenillas ,Lucía Celada ,José Ruiz-Cantador ,Bruna Calsina ,Debayan Datta ,Eduardo García-Galea ,Roberta Fasani ,Ana Belén Moreno-Cárdenas ,Juan José Alba-Linares ,Berta Miranda-Barrio ,Ángel M Martínez-Montes ,Cristina Alvarez-Escola ,Beatriz Lecumberri ,Ana González García ,Shahida K Flores ,Emmanuel Esquivel ,Yanli Ding ,Mirko Peitzsch ,José-Ángel Robles-Guirado ,Rita Maria Regojo Zapata ,José Juan Pozo-Kreilinger ,Carmela Iglesias ,Trisha Dwight ,Christopher A Muir ,Amelia Oleaga ,Maria Elvira Garrido-Lestache Rodríguez-Monte ,Maria Jesús Del Cerro ,Isaac Martínez-Bendayán ,Enol Álvarez-González ,Tamara Cubiella ,Delmar Muniz Lourenço Jr ,Maria Adelaide A Pereira ,Nelly Burnichon ,Alexandre Buffet ,Craig Broberg ,Paxton V Dickson ,Mario F Fraga ,José Luis Llorente Pendás ,Joaquín Rueda Soriano ,Francisco Buendía Fuentes ,Sergio P A Toledo ,Roderick Clifton-Bligh ,Rodrigo Dienstmann ,Josep Villanueva ,Jaume Capdevila ,Anne-Paule Gimenez-Roqueplo ,Judith Favier ,Paolo Nuciforo ,William F Young Jr ,Nicole Bechmann ,Alexander R Opotowsky ,Anand Vaidya ,Irina Bancos ,Donate Weghorn ,Mercedes Robledo ,Anna Casteràs ,Laura Dos-Subirà ,Igor Adameyko ,María-Dolores Chiara ,Patricia L M Dahia ,Rodrigo A Toledo

A Phase Ib Study of the DNA-PK Inhibitor Peposertib Combined with Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal Cancer

DNA-PK 抑制剂 Peposertib 联合新辅助放化疗治疗局部晚期直肠癌患者的 Ib 期研究

Paul B Romesser, Jaume Capdevila, Rocio Garcia-Carbonero, Tony Philip, Carlos Fernandez Martos, Richard Tuli, Almudena Rodriguez-Gutierrez, Mirjam Kuipers, Andreas Becker, Anna Coenen-Stass, Barbara Sarholz, Xiaoli You, Eric D Miller0

SEOM-GETNE clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2022)

SEOM-GETNE 胃肠胰和支气管神经内分泌肿瘤(NENs)诊断和治疗临床指南(2022)

Castillón, Jaume Capdevila; Gordoa, Teresa Alonso; Bayonas, Alberto Carmona; Carretero, Ana Custodio; García-Carbonero, Rocío; Pulido, Enrique Grande; Fonseca, Paula Jiménez; Lete, Angela Lamarca; Huerta, Angel Segura; Plazas, Javier Gallego

A Novel Antagonistic CD73 Antibody for Inhibition of the Immunosuppressive Adenosine Pathway

一种新型的CD73拮抗抗体,用于抑制免疫抑制性腺苷通路

Melanie Wurm # ,Otmar Schaaf # ,Katharina Reutner # ,Rajkumar Ganesan ,Sven Mostböck ,Christina Pelster ,Jark Böttcher ,Bruna de Andrade Pereira ,Christina Taubert ,Isabella Alt ,Garazi Serna ,Aurelie Auguste ,Kai B Stadermann ,Denis Delic ,Fei Han ,Jaume Capdevila ,Paolo G Nuciforo ,Rachel Kroe-Barrett ,Paul J Adam ,Anne B Vogt ,Irmgard Hofmann

Impact of circulating tumor DNA mutant allele fraction on prognosis in RAS-mutant metastatic colorectal cancer

循环肿瘤 DNA 突变等位基因部分对 RAS 突变转移性结直肠癌预后的影响

Elena Elez, Chiara Chianese, Enrique Sanz-García, Erica Martinelli, Alba Noguerido, Francesco Mattia Mancuso, Ginevra Caratù, Judit Matito, Julieta Grasselli, Claudia Cardone, Riziero Esposito Abate, Giulia Martini, Cristina Santos, Teresa Macarulla, Guillem Argilés, Jaume Capdevila, Ariadna Garcia,

Phase II Study of Everolimus and Octreotide LAR in Patients with Nonfunctioning Gastrointestinal Neuroendocrine Tumors: The GETNE1003_EVERLAR Study

依维莫司和奥曲肽 LAR 治疗无功能性胃肠道神经内分泌肿瘤患者的 II 期研究:GETNE1003_EVERLAR 研究

Jaume Capdevila, Alexandre Teulé, Jorge Barriuso, Daniel Castellano, Carlos Lopez, Jose Luis Manzano, Vicente Alonso, Rocío García-Carbonero, Emma Dotor, Ignacio Matos, Ana Custodio, Oriol Casanovas, Ramon Salazar; EVERLAR study investigators

Management of controversial gastroenteropancreatic neuroendocrine tumour clinical situations with somatostatin analogues: results of a Delphi questionnaire panel from the NETPraxis program

使用生长抑素类似物治疗有争议的胃肠胰神经内分泌肿瘤临床情况:NETPraxis 计划的德尔菲问卷调查小组的结果

Isabel Sevilla, Ángel Segura, Jaume Capdevila, Carlos López, Rocío García-Carbonero, Enrique Grande; GETNE (Spanish Group of NeuroEndocrine Tumors)

A randomized phase II study of capecitabine-based chemoradiation with or without bevacizumab in resectable locally advanced rectal cancer: clinical and biological features

卡培他滨为基础的放化疗联合或不联合贝伐单抗治疗可切除局部晚期直肠癌的随机 II 期研究:临床和生物学特征

Ramon Salazar, Jaume Capdevila, Berta Laquente, Jose Luis Manzano, Carles Pericay, Mercedes Martínez Villacampa, Carlos López, Ferran Losa, Maria Jose Safont, Auxiliadora Gómez, Vicente Alonso, Pilar Escudero, Javier Gallego, Javier Sastre, Cristina Grávalos, Sebastiano Biondo, Amalia Palacios, Enri